Validation of the Japanese version of the Chronic Liver Disease Questionnaire for the assessment of health‐related quality of life in patients with chronic viral hepatitis

Tanaka, Atsushi; Kikuchi, Kentaro; Miura, Ryo; Miura, Kotaro; Mikami, Masaki; Aiso, Mitsuhiko; Takamori, Yoriyuki; Takikawa, Hajime

doi:10.1111/hepr.12524

Cited by 22 publications

(26 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Table shows the HRQOL assessed using the Japanese version of the CLDQ in this study cohort . At baseline, the mean overall CLDQ score was 5.43, and the mean CLDQ scores for the various individual domains were 5.83 for abdominal symptoms, 5.18 for fatigue, 5.32 for systemic symptoms, 5.83 for activity, 5.43 for emotional function, and 5.32 for worry.…”

Section: Resultsmentioning

confidence: 94%

“…The CLDQ is widely used as a validated disease‐specific HRQOL instrument developed specifically for patients with chronic liver disease . The Japanese version of the CLDQ has been reported to be reliable and valid for the assessment of the HRQOL of Japanese patients with chronic viral hepatitis . The Japanese version of the CLDQ questionnaire was self‐administered by patients treated with DCV/ASV in this hospital and was administered at baseline; weeks 4, 12, and 24; and post‐24 weeks.…”

Section: Methodsmentioning

confidence: 99%

“…Various evaluations of HRQOL in patients with HCV infection have been obtained through numerous studies over the last 10 years, mainly using CLDQ. Previous assessments revealed the following landmark insights: the HRQOL in HCV patients is lower than the general population; worsening of disease severity is associated with lower HRQOL; HCV elimination by antiviral treatment improves the HRQOL in HCV patients; and the HRQOL in HCV patients receiving the IFN‐ and ribavirin (RBV)‐free DAA regimen improves during the treatment, in contrast to a decrease of the HRQOL during the treatment of HCV patients undergoing regimens including IFN and/or RBV …”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Daclatasvir and asunaprevir improves health‐related quality of life in Japanese patients infected with hepatitis C virus

et al. 2018

Self Cite

View full text Add to dashboard Cite

AimsInterferon‐free direct‐acting antiviral agent (DAA) regimens for chronic hepatitis C virus (HCV) patients have improved their health‐related quality of life (HRQOL). Currently, there are no published data assessing the impact of DAAs regimens without sofosbuvir on HRQOL. The aim of this study was to investigate the improvement of HRQOL in Japanese HCV patients treated with a protease inhibitor and a nonstructural protein 5A inhibitor.Methods and ResultsA total of 123 Japanese genotype 1b HCV patients receiving daclatasvir (DCV) and asunaprevir (ASV) for 24 weeks were enrolled. HRQOL was assessed using the Japanese version of the Chronic Liver Disease Questionnaire (CLDQ) at baseline; weeks 4, 12, and 24; and post‐24 weeks. Changes in CLDQ scores were calculated by subtracting the CLDQ score at each time point from the baseline value. Improvement in the mean change of the Japanese version of the CLDQ score became statistically significant as early as week 4 after the initiation of treatment (+9.3%; P < 0.0001) and was sustained during and after DCV/ASV treatment. The changes of CLDQ at posttreatment week 24 in patients with sustained virological responses (SVR) were significantly higher than those in patients without SVR (0.4% and −4.1%, respectively; P < 0.05).ConclusionsThis study of DCV/ASV treatment for Japanese HCV patients in a clinical setting demonstrated that HRQOL can improve as early as at the initiation of treatment and can continue during and after treatment, regardless of the classes of DAAs regimens and race. Moreover, SVR are needed to continue HRQOL improvement.

show abstract

Section: Resultsmentioning

confidence: 94%

Section: Methodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Daclatasvir and asunaprevir improves health‐related quality of life in Japanese patients infected with hepatitis C virus

et al. 2018

Self Cite

View full text Add to dashboard Cite

show abstract

“…According to the criteria of a good questionnaire, the Cronbach's value should be more than 0.7, the ceiling effect and flooring effect should less than 20%, and the intern consistency should more than 0.6 [5][6][7][8]. From the 111 items of LDQOL, we selected 30 items which met the above criteria.…”

Section: Discussionmentioning

confidence: 99%

Study on Short Version of Liver Disease Quality of Life Questionnaire (LDQOL) and Its Reliability and Validity

Minghua¹,

Xinxin²,

Huang³

et al. 2016

Chemotherapy (Los Angel)

View full text Add to dashboard Cite

Objective: To make item analysis on Liver Disease Quality of Life Questionnaire (LDQOL) and to develop a short version questionnaire.Methods: LDQOL were administered to 256 chronic liver disease patients, item analysis of LDLQOL was made and short version of LDQOL was developed based on the results of item analysis. Cronbach's α coefficient of both the original one and the short version one was calculated. Results:The original questionnaire ceiling effect was from 0-39.6%; flooring effect 0 from 0-34.1%; Cronbach's coefficient from 0.27 to 0.97. The short version scale questionnaire was made up of the 30 items with better ceiling effect (0-29.0%), flooring effect (0); Cronbach's α coefficient (0.92 to 0.98). The correlation coefficient between the original one and that of the short version one was 0.935. Conclusion:The short version of LDQOL has a higher reliability and good validity.

show abstract

“…) and Asian (Persian, 12 Thai, 13 Japanese, 14 Chinese, 15 Bengali 16 and Srilankan 17 ) languages. Such a cross cultural adaptation enables global comparisons of HRQOL data and also helps in designing international projects.…”

mentioning

confidence: 99%

Translation and validation of the Hindi version of chronic liver disease questionnaire (CLDQ) for the assessment of health related quality of life in patient with chronic liver disease in India

Benjamin¹,

Mani²,

Saraya³

et al. 2016

View full text Add to dashboard Cite

Background: Chronic liver disease questionnaire (CLDQ) is an established disease specific tool to assess the health related quality of life (HRQOL) in patients with CLD irrespective of the etiology and severity. The objective of the study was to develop the Hindi language version of CLDQ and to assess the validity of the Hindi CLDQ. Methods: CLDQ was adapted into Hindi language by following a standard method of forward and back-translation by two bilingual translators, revision by expert panel and formulation of a consensual version followed by pilot testing and appropriate modifications before final administration. Hindi CLDQ along with short form 36 (SF-36) were administered in 494 patients with chronic liver disease (CLD) and 103 healthy controls (HC). To assess reproducibility, Hindi CLDQ was re-administered in a subsample of 20 patients. Internal consistency was assessed by Cronbach's alpha coefficient. Structural validity was assessed by exploratory factor analysis and construct validity was assessed with help of correlation of SF-36 scores and CLDQ pattern across disease severity groups. Results: The Cronbach's alpha coefficient was 0.93 and intra class coefficient correlation was 0.88 for the average CLDQ score, suggestive of good reliability. An inverse relationship of the average CLDQ score with the disease severity (CLDQ score of Child A vs. B vs. C = 5.2±1.10 vs. 4.73±1.24 vs. 4.15±1.19 respectively; p<0.001) and good correlation with SF-36 scores (average CLDQ score with PCS & MCS; r=0.63 & 0.55; p<0.001) was suggestive of good validity of Hindi CLDQ. The factor analysis identified 6 domains accounting for 62% of variability. The derived cut-off of 6 for the average CLDQ had the AUC of 0.826 with a sensitivity of 82.6 and a specificity of 76.7. Conclusion: Hindi version of CLDQ is found to be a reliable and a valid tool comparable to the original English version. The HRQOL of patients with CLD is lower than healthy controls and HRQOL decreases with increase in disease severity.

show abstract

Validation of the Japanese version of the Chronic Liver Disease Questionnaire for the assessment of health‐related quality of life in patients with chronic viral hepatitis

Cited by 22 publications

References 26 publications

Daclatasvir and asunaprevir improves health‐related quality of life in Japanese patients infected with hepatitis C virus

Daclatasvir and asunaprevir improves health‐related quality of life in Japanese patients infected with hepatitis C virus

Study on Short Version of Liver Disease Quality of Life Questionnaire (LDQOL) and Its Reliability and Validity

Translation and validation of the Hindi version of chronic liver disease questionnaire (CLDQ) for the assessment of health related quality of life in patient with chronic liver disease in India

Contact Info

Product

Resources

About